User profiles for P.R. Lockman

Paul Lockman

West Virginia University
Verified email at hsc.wvu.edu
Cited by 9755

Nanoparticle technology for drug delivery across the blood-brain barrier

PR Lockman, RJ Mumper, MA Khan… - Drug development and …, 2002 - Taylor & Francis
Nanoparticles (NP) are solid colloidal particles ranging in size from 1 to 1000 nm that are
utilized as drug delivery agents. The use of NPs to deliver drugs to the brain across the blood-…

Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells

JA Gaasch, PR Lockman, WJ Geldenhuys… - Neurochemical …, 2007 - Springer
Iron accumulation or iron overload in brain is commonly associated with neurodegenerative
disorders such as Parkinson’s and Alzheimer’s diseases, and also plays a role in cellular …

The transport of choline

PR Lockman, DD Allen - Drug development and industrial …, 2002 - Taylor & Francis
Choline has many physiological functions throughout the body that are dependent on its
available local supply. However, since choline is a charged hydrophilic cation, transport …

Nanoparticle surface charges alter blood–brain barrier integrity and permeability

PR Lockman, JM Koziara, RJ Mumper… - Journal of drug …, 2004 - Taylor & Francis
… 1A: 1.20 ^ 0.48 £ 1022 ml/g) agrees with previously published data for an intact BBB (Lockman
et al., 2003a,b). Subsequent experiments shown in Fig. 1A with neutral NPs present in …

Heterogeneous blood–tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer

PR Lockman, RK Mittapalli, KS Taskar, V Rudraraju… - Clinical cancer …, 2010 - AACR
Purpose: Brain metastases of breast cancer appear to be increasing in incidence, confer
significant morbidity, and threaten to compromise gains made in systemic chemotherapy. The …

Paclitaxel nanoparticles for the potential treatment of brain tumors

JM Koziara, PR Lockman, DD Allen… - Journal of controlled …, 2004 - Elsevier
Despite the advances in tumor therapy, patients with primary brain tumors and brain metastases
have a very poor prognosis. Low responses to chemotherapy are mainly attributed to …

Brain uptake of thiamine-coated nanoparticles

PR Lockman, MO Oyewumi, JM Koziara… - Journal of controlled …, 2003 - Elsevier
Recently, a novel nanoparticle (NP) comprised of emulsifying wax and Brij 78 was shown to
have significant brain uptake using the in-situ rat brain perfusion technique. To further these …

Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer

…, D Palmieri, PS Steeg, PR Lockman… - Pharmaceutical …, 2009 - Springer
Purpose We evaluated the uptake of angiopep-2 paclitaxel conjugate, ANG1005, into brain
and brain metastases of breast cancer in rodents. Most anticancer drugs show poor delivery …

In Situ Blood–Brain Barrier Transport of Nanoparticles

JM Koziara, PR Lockman, DD Allen… - Pharmaceutical …, 2003 - Springer
Purpose. Two novel types of nanoparticles were evaluated as potential carriers for drugs
across the blood–brain barrier (BBB). Methods. Nanoparticles were composed of …

Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases

Z Cui, PR Lockman, CS Atwood, CH Hsu… - European journal of …, 2005 - Elsevier
Metal ions accumulate in the brain with aging and in several neurodegenerative diseases.
Aside from the copper storage disease, Wilson's disease, recent attention has focused on the …